PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 14.2 MILLION PRIVATE PLACEMENT, PRIMARILY SUSBCRIBED BY LONG TERM INVESTOR AB SCIENCE CASH POSITION IS AROUND EUR 23 MILLION AFTER THIS PRIVATE PLACEMENT, THEREBY ALLOWING THE COMPANY TO CARRY-OUT WITHOUT ANY ADDITIONAL NEAR-TERM FINANCING THE FIRST STEPS OF ITS STRATEGIC PLAN TO BE FINALIZED AND ANNOUNCED IN SEPTEMBER Paris, August 10, 2026, 8am AB Science S.A. (the “Company” or “AB Science”, Euronext – FR0010557264 – AB) announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million subscribed by a limited number of investors (the “Private Placement”). The capital increase was subscribed for EUR 12 million by an existing long-term investor who expressed its intention to accompany the development of the Company. Stéphane...

Sampo plc, stock exchange release, 10 August 2026 at 8:30 am EEST Sampo plc’s share buybacks week 32/2026 During week 32 (3 August 2026 – 7 August 2026), Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:Market (MIC Code) Daily volume (in number of shares) and weighted average price of the purchased shares, EUR* Aggregated weekly volume (in number of shares) and weighted weekly average price of the purchased shares, EUR*    03/08/2026 04/08/2026 05/08/2026 06/08/2026 07/08/2026 Week 32/2026, totalAQEU Volume 1,181 80,775 7,287 0 0 89,243Average price 9.56 9.42 9.49 0.00 0.00 9.43CEUX Volume 154,113 426,124 182,915 0 798 763,950Average price 9.58 9.43 9.48 0.00 9.57 9.47TQEX Volume 41,201 44,811 41,940 0 730 128,682Average price 9.58 9.42 9.48 0.00 9.56 9.49XHEL Volume 206,403 736,319 224,739 0 747 1,168,208Average...

Press ReleaseNicox Announces NCX 470 NDA Submission in China by Partner OcumensionOcumension has submitted the New Drug Application (NDA) to the Chinese National Medical Products Administration (NMPA) for NCX 470 to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension Same data package as for the recent submission in the U.S. Ocumension already has an ophthalmology sales force throughout China Multiple NCX 470 clinical, approval and launch milestone events expected over the next 12 to 18 monthsAugust 10, 2026 – release at 7:30 am CET CONFIDENTIAL DRAFTSophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that its exclusive licensee in China, Ocumension Therapeutics, has submitted the New Drug Application...

CALGARY, Alberta, Aug. 07, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura“) announces that the development well Maru-3, in the Maru Lease, has been successfully completed in the Pirkoh Limestone formation of Eocene age. During a post-completion test on a 64/64 inch choke, the well flowed conventional natural gas at an average rate of approximately 1.02MMcf/d with an average wellhead flowing pressure of approximately 105 psi. The development well Maru-3 was drilled to a total measured depth of 951 meters. After tie-in with the production facilities, the well has been put on production and is currently producing approximately 0.7 MMcf/d of gas. The production is expected to increase after production build-up survey and acid simulation, which is currently planned to be carried out in Q4 2026. The Maru Lease covers...

DENVER, Aug. 07, 2026 (GLOBE NEWSWIRE) — Pure Cycle Corporation (NASDAQ Capital Market: PCYO) (“Pure Cycle”, “we”, “us” or “our”) today confirmed that it has received notice from Maran Partners Fund, LP, a fund managed by Maran Capital Management, LLC (“Maran”), that it has nominated five individuals to stand for election to the Pure Cycle Board of Directors at the Company’s 2027 Annual Meeting of Shareholders. The Board’s Nominating and Corporate Governance Committee will review the proposed nominees in accordance with the Company’s process and guidelines. The Board will make its formal recommendation regarding director nominations in the Company’s proxy statement, which will be filed with the Securities and Exchange Commission (the “SEC”) and mailed to shareholders eligible to vote at the 2027 Annual Meeting of Shareholders. Company...

CALGARY, Alberta, Aug. 07, 2026 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company“) announces that its board of directors has approved the consolidation (the “Consolidation“) of the Company’s issued and outstanding common shares (“Common Shares“) on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation will become effective at the opening of trading on August 12, 2026. Commencing on that date, the Common Shares will trade on the Canadian Securities Exchange (the “CSE”) on a post-Consolidation basis under the existing trading symbol “GURN”. The Company currently has 59,158,004 Common Shares issued and outstanding. Upon completion of the Consolidation, the Company...